Patients rely on supports like the 340B program, which provides discounts on essential prescription drugs to vulnerable communities.

I hope today can be a start on finding bipartisan solutions to make healthcare pricing more transparent.

I have seen the price of insulin go up from about $40 a bottle to north of 300 now.

I have a bill with Henry Cuellar of Laredo. It is a bipartisan bill to repeal the ban on physician-owned hospitals.

I don't think there is anything that hospitals should be afraid of when it comes to 340B transparency.

the 340B drug-pricing program was created in 1992 and aimed at enabling certain healthcare providers known as covered entities--and this is a quote--to stretch scarce Federal resources to reach more eligible patients or provide more…

Starting in the mid-2000s, big hospital chains figured out how to supercharge the program.

Nobody--Democrat, Republican, independent, anybody--should be harmed by medical expenses.

Site-neutral policies are also a tool to help strengthen the Medicare program overall.

In Massachusetts, outside of cities like Boston, we have lower-income communities that rely on stand-alone providers.

Improving healthcare price transparency, however, would inject needed competition for healthcare facilities and ultimately lower costs for patients.

I am happy and ready to work on combating some of these perverse incentives for pharmacy benefit managers.

The current healthcare system is gobbledygook.

myself and many other individuals warned that prices would go up, that premiums would go up with the passage of the Affordable Care Act

I support the 340B program, and I want to see it succeed.

It is imperative for the Biden administration to conduct greater enforcement efforts on these rules to better serve patients.

Shining a light on middlemen who are making prescriptions more expensive is one important step to bolster competition.

I think that insurers need to negotiate prices to lower hospital costs.